Assertion list for term "new drug".

Results from Ascent++: 134
new drug (subgroup of drug) HasPropertyeffective 0.77
new drug (subgroup of drug) HasPropertysafe 0.76
new drug (subgroup of drug) ReceivesActionapproved by the fda 0.76
new drug (subgroup of drug) CapableOfenter the market 0.76
new drug (subgroup of drug) ReceivesActionapproved 0.69
new drug (subgroup of drug) ReceivesActiontested 0.67
new drug (subgroup of drug) ReceivesActionbrought to market 0.66
new drug (subgroup of drug) ReceivesActiondeveloped 0.64
new drug (subgroup of drug) ReceivesActioncreated 0.59
new drug (subgroup of drug) CapableOfenter clinical trials 0.57
new drug (subgroup of drug) ReceivesActiontested in clinical trials 0.57
new drug (subgroup of drug) CapableOfbecome available 0.57
new drug (subgroup of drug) ReceivesActionsold 0.55
new drug (subgroup of drug) ReceivesActionintroduced 0.55
new drug (subgroup of drug) ReceivesActionproven safe 0.54
new drug (subgroup of drug) ReceivesActiondescribed in section 505(a 0.54
new drug (subgroup of drug) ReceivesActiontested on animal 0.54
new drug (subgroup of drug) ReceivesActionprescribed 0.53
new drug (subgroup of drug) ReceivesActioninvestigated 0.53
new drug (subgroup of drug) ReceivesActionpatented 0.52
new drug (subgroup of drug) CapableOfreceive fda approval 0.51
new drug (subgroup of drug) ReceivesActionsynthesized 0.51
new drug (subgroup of drug) ReceivesActionreleased 0.47
new drug (subgroup of drug) HasPropertyexpensive 0.47
new drug (subgroup of drug) ReceivesActionprotected by patent 0.46
new drug (subgroup of drug) CapableOfprove effective 0.46
new drug (subgroup of drug) ReceivesActionadded 0.46
new drug (subgroup of drug) HasPropertyexcellent 0.45
new drug (subgroup of drug) ReceivesActionmarketed 0.44
new drug (subgroup of drug) CapableOfshown promise 0.43
new drug (subgroup of drug) ReceivesActionlaunched 0.42
new drug (subgroup of drug) ReceivesActioncompared with placebo 0.42
new drug (subgroup of drug) CapableOftreat cancer 0.40
new drug (subgroup of drug) ReceivesActionapproved in the u.s. 0.40
new drug (subgroup of drug) ReceivesActioninjected into the eye 0.40
new drug (subgroup of drug) IsAinvented the company 0.40
new drug (subgroup of drug) HasPropertysuperior 0.39
new drug (subgroup of drug) CapableOfsave life 0.39
new drug (subgroup of drug) ReceivesActionreviewed 0.39
new drug (subgroup of drug) CapableOfshow promise 0.38
new drug (subgroup of drug) ReceivesActionreimbursed 0.38
new drug (subgroup of drug) CapableOftreat disease 0.38
new drug (subgroup of drug) HasPropertysuccessful 0.38
new drug (subgroup of drug) IsAantibody 0.37
new drug (subgroup of drug) HasPropertymore effective 0.37
new drug (subgroup of drug) HasPropertybeneficial 0.37
new drug (subgroup of drug) CapableOftreat alzheimer 0.37
new drug (subgroup of drug) ReceivesActionstudied 0.36
new drug (subgroup of drug) CapableOfcure hepatitis c 0.35
new drug (subgroup of drug) ReceivesActionlicensed for use 0.35
new drug (subgroup of drug) HasAside effects 0.34
new drug (subgroup of drug) ReceivesActiondiscovered 0.34
new drug (subgroup of drug) CapableOfhelp people 0.34
new drug (subgroup of drug) HasAthe effect 0.34
new drug (subgroup of drug) IsAon the horizon 0.34
new drug (subgroup of drug) IsAimprovement 0.34
new drug (subgroup of drug) ReceivesActionstarted 0.34
new drug (subgroup of drug) HasPropertydangerous 0.34
new drug (subgroup of drug) AtLocationthe pipeline 0.33
new drug (subgroup of drug) CapableOfreceive approval 0.32
new drug (subgroup of drug) CapableOfawait approval 0.32
new drug (subgroup of drug) CapableOfreach patient 0.32
new drug (subgroup of drug) CapableOftreat advanced cases of multiple sclerosis 0.32
new drug (subgroup of drug) ReceivesActiontested on mouse 0.32
new drug (subgroup of drug) ReceivesActionregistered 0.31
new drug (subgroup of drug) ReceivesActiontested against placebo 0.31
new drug (subgroup of drug) CapableOftarget enzyme 0.30
new drug (subgroup of drug) CapableOftarget protein 0.30
new drug (subgroup of drug) CapableOftreat depression 0.30
new drug (subgroup of drug) CapableOfoffer hope 0.29
new drug (subgroup of drug) HasAfewer side effects 0.29
new drug (subgroup of drug) CapableOfbe a godsend 0.28
new drug (subgroup of drug) CapableOftake year 0.28
new drug (subgroup of drug) CapableOfprevent heart attacks 0.28
new drug (subgroup of drug) HasPropertyless toxic 0.28
new drug (subgroup of drug) HasPropertybetter than old ones 0.28
new drug (subgroup of drug) ReceivesActionhad to clear high bar 0.28
new drug (subgroup of drug) ReceivesActionapproved by health canada 0.28
new drug (subgroup of drug) ReceivesActionstudied in child 0.28
new drug (subgroup of drug) ReceivesActionused in combination 0.28
new drug (subgroup of drug) ReceivesActionapproved in 2017 0.28
new drug (subgroup of drug) ReceivesActionpresented as breakthrough 0.28
new drug (subgroup of drug) ReceivesActionadded to the formulary 0.28
new drug (subgroup of drug) ReceivesActionapproved in 2015 0.28
new drug (subgroup of drug) CapableOfcure the disease 0.27
new drug (subgroup of drug) CapableOftreat hiv 0.25
new drug (subgroup of drug) HasPropertysafer 0.25
new drug (subgroup of drug) CapableOftreat infectious diseases 0.25
new drug (subgroup of drug) CapableOftreat opioid addiction 0.25
new drug (subgroup of drug) CapableOfimprove survival 0.25
new drug (subgroup of drug) CapableOftarget receptor 0.25
new drug (subgroup of drug) CapableOfbenefit child 0.25
new drug (subgroup of drug) CapableOfextend life 0.25
new drug (subgroup of drug) CapableOfreverse two major risk factors 0.25
new drug (subgroup of drug) CapableOftarget same diseases 0.25
new drug (subgroup of drug) CapableOfbecome popular 0.25
new drug (subgroup of drug) CapableOfimprove treatment of the symptoms 0.25
new drug (subgroup of drug) CapableOfcarry out autopsy 0.25
new drug (subgroup of drug) CapableOfaddress unmet medical needs 0.25
new drug (subgroup of drug) HasAnovel mechanisms of action 0.25
new drug (subgroup of drug) HasPropertyidentical 0.25
new drug (subgroup of drug) IsAmonoclonal antibodies 0.25
new drug (subgroup of drug) IsApill 0.25
new drug (subgroup of drug) ReceivesActionintended for use 0.25
new drug (subgroup of drug) ReceivesActiontested on cell 0.25
new drug (subgroup of drug) ReceivesActiondeveloped by amgen 0.25
new drug (subgroup of drug) ReceivesActionlaunched in canada 0.25
new drug (subgroup of drug) ReceivesActionclose to decade 0.25
new drug (subgroup of drug) ReceivesActionrequired 0.25
new drug (subgroup of drug) ReceivesActionapproved under anda 0.25
new drug (subgroup of drug) ReceivesActiontested in the united states 0.25
new drug (subgroup of drug) ReceivesActionapproved for public use 0.25
new drug (subgroup of drug) ReceivesActiontargeted 0.25
new drug (subgroup of drug) ReceivesActionused in concert 0.25
heroin IsAnew drug 0.25
new drug (subgroup of drug) CapableOfhit street 0.23
new drug (subgroup of drug) HasPropertyineffective 0.23
new drug (subgroup of drug) ReceivesActiondeveloped to treat tb 0.23
new drug (subgroup of drug) ReceivesActionintended to treat serious conditions 0.23
new drug (subgroup of drug) CapableOfinteract with thyroidal axis 0.22
new drug (subgroup of drug) CapableOfactivate immune system 0.19
new drug (subgroup of drug) CapableOflook good 0.19
new drug (subgroup of drug) ReceivesActiontolerated 0.19
new drug (subgroup of drug) ReceivesActionused at lower doses 0.19
new drug (subgroup of drug) CapableOfwork in different way 0.16
new drug (subgroup of drug) CapableOfreduce blood glucose levels 0.16
new drug (subgroup of drug) CapableOfimprove cognition 0.16
new drug (subgroup of drug) CapableOftreat lupus 0.16
new drug (subgroup of drug) CapableOflast at least 30 days 0.16
new drug (subgroup of drug) HasPropertyunsafe 0.16
new drug (subgroup of drug) HasPropertylife-changing 0.16
new drug (subgroup of drug) CapableOftreat tuberculosis 0.09
new drug (subgroup of drug) ReceivesActionremoved 0.09
new drug (subgroup of drug) ReceivesActionapproved for motor neurone disease 0.00